| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |